Simultaneous Detection of Antigen and Antibodies of African Swine Fever in a Novel Combo Lateral Flow Assay

Cristina Aira,Gabriela González-García,Juan Martínez-Cano,Nuria de la Roja,Monica Giammarioli,Francesco Feliziani,Žanete Šteingolde,Jurate Buitkuviene,Petr Václavek,Dimitrije Glišić,Carmina Gallardo,Patricia Sastre,Marga García-Durán,Paloma Rueda,Alba Fresco-Taboada

DOI: https://doi.org/10.3390/vaccines12030307

2024-03-15

Vaccines

Abstract:African swine fever (ASF) is a contagious disease of wild boar and domestic pigs notifiable to the World Organisation for Animal Health due to its high socio-economic impact. ASF is caused by the complex ASF virus (ASFV), and it can present different clinical manifestations that can be confused with other diseases; for this reason, laboratory testing is necessary for the proper diagnosis of clinically suspected animals. Despite the efforts put into it over decades, no treatment or safe vaccine is globally available, and disease control is based on early diagnosis and the implementation of strict biosecurity measures. In this context, rapid tests have the potential to accelerate and facilitate the identification of infected animals by giving fast on-site results. In this work, we improved the available point-of-care assays for the diagnosis of the disease by the development of a more specific antigen test and a more sensitive antibody test. This antibody detection test allowed for the earlier detection of infected animals than two commercial indirect ELISAs (statistically significant). Moreover, we developed a combined dual rapid test, unifying, in the same cassette, an antigen detection strip and an antibody detection strip. In this study, we confirmed that this combo approach is a useful tool for implementing rapid tests in the field since it increases the percentage of positive samples detected, even when PCR turns negative, while maintaining a good specificity.

immunology,medicine, research & experimental

What problem does this paper attempt to address?

The paper primarily addresses two key issues in the diagnosis of African Swine Fever (ASF):

1. **Improving the specificity of antigen detection**: A new antigen detection kit (INgezim®ASFV CROM Ag 2.0) based on recombinant antibodies targeting the ASF virus p72 protein was developed to enhance the accuracy of antigen detection in the early stages of infection. Evaluation of experimental samples showed that the new kit has comparable detection capabilities in the early stages of infection compared to existing similar products on the market.

2. **Enhancing the sensitivity of antibody detection**: A new antibody detection kit (INgezim®ASFV CROM Ab 2.0) based on recombinant p72 protein was developed to enable earlier detection of low-titer antibody samples. The study showed that the new antibody detection method significantly improves the antibody detection rate in the early stages of infection compared to previous products and has higher sensitivity in the early stages of infection compared to two commercial indirect ELISAs.

Additionally, to combine the advantages of antigen and antibody detection, researchers developed a combo rapid test card (Combo test) that allows parallel detection of antigens and antibodies on the same test card. This is of great significance for rapid on-site diagnosis and monitoring of African Swine Fever. This combined detection method maintains good specificity while increasing the detection rate of positive samples, especially in cases where PCR results have turned negative but infection can still be detected.